Year: 2023

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) — Shawcor Ltd., dba Mattr Infratech (“Mattr” or the “Company”) (TSX: MATR) reported today its operational and financial results for the three and nine months ended September 30, 2023. This press release should be read in conjunction with the Company’s Management Discussion and Analysis (“MD&A”) and interim consolidated financial statements for the three and nine months ended September 30, 2023, which are available on the Company’s website and at www.sedarplus.com. Highlights from the third quarter include1:The Company entered into a definitive agreement to sell a substantial part of its Pipeline Performance Group (“PPG”) business which was previously reported under the Pipeline and Pipe Services (“PPS”) segment for $166 million USD, or approximately $230 million CAD at October 31,...

Biologics License Application for cosibelimab under review by U.S. FDA; PDUFA goal date of January 3, 2024 Recent publication of cosibelimab pivotal trial results in the Journal for ImmunoTherapy of Cancer WALTHAM, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the third quarter ended September 30, 2023, and recent corporate highlights. “The January 3, 2024, action date for our Biologics License Application (“BLA”) for cosibelimab is fast-approaching, and we continue to work closely with the U.S. Food and Drug Administration (“FDA”) in completing their review,” said James Oliviero, President and Chief Executive Officer of Checkpoint. “During the third quarter, pivotal trial results...

Quarterly net revenues were RMB445.6 million (US$61.1 million),1 an increase of 33.5% year-over-yearQuarterly lidar shipments were 47,4402 units, an increase of 125.5% year-over-year SHANGHAI, China, Nov. 13, 2023 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”), (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced its unaudited financial results for the three months ended September 30, 2023. Operational Highlights  Three months endedSeptember 30, 2023   Nine months endedSeptember 30, 2023ADAS lidar shipments 40,593   114,482Autonomous Mobility lidar shipments 6,847   19,898Total lidar shipments 47,440   134,380Q3 2023 ADAS lidar shipments were 40,593 units, compared to 16,694 units in the corresponding period of 2022. Q3 2023 Total lidar...

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, Nov. 13, 2023 (GLOBE NEWSWIRE) — Northview Residential REIT (“Northview” or the “REIT”, formerly Northview Fund) (NRR.UN – TSX), today announced financial results for the three and nine months ended September 30, 2023. All amounts in this news release are in thousands of Canadian dollars unless otherwise indicated. In August 2023, Northview’s units were consolidated on a 1.75 to 1.00 basis. All references to the number of units and per unit amounts in this news release have been restated and are reflected on a post-consolidation basis.“We were pleased that occupancy and AMR continued to improve through the third quarter of 2023, emphasizing the strong fundamentals of the multi-residential real estate market. Northview’s...

KAPALUA, Hawaii, Nov. 13, 2023 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the nine months ended September 30, 2023. “Following the August wildfires on Maui, we continue to focus on resiliency by supporting current and future needs of the community through an increased housing supply, food and water security, and renewed connections of people and place. As the stewards of land and commercial property on Maui, our mission is to meet these critical needs by carefully ensuring our assets are actively used to their fullest potential. Nearly all our current tenants have reopened their businesses following the fires; however, the impacts from their temporary closures and reduced sales caused a decrease in lease revenue for the company in the third quarter. This, combined...

ROUND ROCK, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) — TSS, Inc. (Other OTC: TSSI), a data center facilities and technology integration services company, reported results for its third quarter ended September 30, 2023. “We continued to produce strong financial results during the third quarter as we improved efficiency through operational investments. We are beginning to see the benefits of our expanded sales initiatives as we integrate hardware and software technologies into useable solutions that enable data centers and the Internet to function,” said Darryll E. Dewan, President and CEO of TSS. “We continue to invest in our foundation and plan that will benefit our growth and financial performance going forward. We will continuously improve the solutions and services we provide to the market.” Third Quarter Highlights (unaudited):Third...

AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the first quarter of fiscal year 2024, which ended September 30, 2023. Financial Highlights & Recent Developments Astrotech’s consolidated balance sheet remains strong with $39 million in cash and liquid investments, which are anticipated to support our research and development, organic growth, and potential acquisition targets. Revenue for the quarter totaled $425 thousand compared to $38 thousand in the first quarter of the prior year due primarily to ongoing fulfillment of the previously announced 17-unit order for the TRACER 1000™ explosives trace detector (ETDs) to a Romania-based security and telecommunications company and ongoing maintenance services and sales...

– Updated luvelta data from Compassionate Use Access demonstrating anti-leukemic activity in pediatric patients with relapsed/refractory CBF2AT3-GLIS2 AML to be presented in a poster at ASH 2023 – – Luvelta demonstrated encouraging preliminary anti-tumor activity in initial data from the Phase 1 dose-expansion study for patients with endometrial cancer presented at ESMO 2023 – – Dr. Hans-Peter Gerber joined Sutro as Chief Scientific Officer in September 2023 – – As of September 30, 2023, Sutro had cash and investments of $321.1 million and shares of Vaxcyte common stock valued at $34.0 million, which together provide a projected cash runway into the first half of 2025 – SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:...

– On track to dose 15-20 patients with higher dose cNeT by year-end 2023 – – Clinical and translational science data update from the ongoing Phase I/IIa trials in NSCLC and melanoma expected in Q1 2024 with additional data available in mid-2024 – – Strong cash position of $140 million supports operations through 2025 –         LONDON, Nov. 13, 2023 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors, today announced its financial results for the quarter ended September 30, 2023, and recent business highlights. “We are pleased with progress across the scientific field that continues to demonstrate the importance of neoantigens as the most attractive targets in solid-tumor oncology....